CRYSTALLINE GABAPENTIN

摘要

The invention relates to a new crystalline polymorph of gabapentin and processes for producing the crystalline gabapentin. More particularly, it relates to the preparation of new crystalline form of gabapentin, referred to as 'Form IV' and pharmaceutical compositions that include the 'Form IV'. It also relates to a method of treatment of cerebral disorder comprising administration of the 'Form IV'.